Animal models carrying mutations in GBA have recently been described in the context of PD [91-93], while other animal models focus on altering the intracellular signaling of neurotrophic factors like Smad3 or on the mechanisms of aggregation of α-syn. This evidence concerns the gene GBA1 and Parkinson disease.